COLCHICINE
| Brand name | MITIGARE |
|---|---|
| Active ingredient | COLCHICINE |
| Strength | 0.6MG |
| Dosage form | CAPSULE |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | September 2014 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 9555029 | August 2033 | use U-1020 |
| 9789108 | August 2033 | use U-1020 |
| 9675613 | August 2033 | use U-1020 |
| 8927607 | August 2033 | use U-1020 |
| 9399036 | August 2033 | use U-1020 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.